Paul Choi
Stock Analyst at Goldman Sachs
(0.82)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
AMRN Amarin Corp | Maintains: Sell | 7 12 | 14.88 | -19.35% | 8 | Jun 25, 2025 | |
URGN UroGen Pharma | Maintains: Neutral | 16 3 | 18.27 | -83.58% | 4 | May 22, 2025 | |
GOSS Gossamer Bio | Maintains: Strong Buy | 7 8 | 1.74 | 359.77% | 6 | May 16, 2025 | |
PHAT Phathom Pharmaceutic... | Maintains: Neutral | 10 5 | 10.3 | -51.46% | 10 | May 2, 2025 | |
ARVN Arvinas | Maintains: Neutral | 12 8 | 6.58 | 21.58% | 3 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 52 | 34.12 | 52.4% | 2 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 21 | 4.28 | 390.65% | 8 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 12 | 7.46 | 60.86% | 3 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 3 | 1.85 | 62.16% | 9 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 12 10 | 10.47 | -4.49% | 4 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 200 225 | 195.94 | 14.83% | 4 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 143 | 56.07 | 155.04% | 1 | Dec 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 32 42 | 43.3 | -3% | 7 | Dec 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 85 60 | 33.2 | 80.72% | 2 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 17 19 | 15.44 | 23.06% | 6 | Aug 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 22 32 | 32.74 | -2.26% | 1 | Jul 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 29 50 | 48.24 | 3.65% | 6 | Jul 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 19 | 4.69 | 305.12% | 3 | Jun 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 400 50 | 8.4 | 495.24% | 7 | Jun 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 29 26 | 2.65 | 881.13% | 2 | Apr 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 29 4 | 1.54 | 159.74% | 1 | Oct 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 25 | 1.4 | 1685.71% | 3 | May 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 450 100 | n/a | n/a | 3 | May 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 4 | n/a | n/a | 4 | May 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 4 | 5.87 | -40.37% | 1 | Apr 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 151 170 | 13.43 | 1165.82% | 2 | Oct 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 225 125 | n/a | n/a | 2 | Sep 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 9 8 | 4.85 | 64.95% | 4 | Aug 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 132 | 178.75 | -26.15% | 3 | Mar 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 33 | 30 | 10% | 1 | Mar 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 112 | 46.99 | 138.35% | 1 | Mar 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 30 | 26.98 | 11.19% | 1 | Jan 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 28 | n/a | n/a | 1 | Aug 11, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 48 49 | n/a | n/a | 4 | Jul 15, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 91 103 | n/a | n/a | 2 | Jul 1, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 135 | 123.99 | 8.88% | 1 | Jun 29, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 240 | 0.7 | 34185.71% | 2 | Jun 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 5 22 | n/a | n/a | 3 | Apr 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 270 300 | 22.48 | 1234.52% | 2 | Mar 30, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 40 | n/a | n/a | 3 | Oct 31, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 60 56 | 74.96 | -25.29% | 3 | Aug 6, 2018 |